Susan Y. Chon

The University of Texas MD Anderson Cancer Center

Also affiliated with The University of Texas Health Science Center at Houston

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit”.

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit

Cancer(2021)10.1002/cncr.34004

N/A

0.890DataRank · unranked

21 citations

Sahira Farooq, Macartney Welborn, Rodabe N. Amaria, Susan Y. Chon, Adi Diab +13 more

Cutaneous Toxicities in the Setting of Immune Checkpoint Blockade:

Surgical pathology clinics(2021)10.1016/j.path.2021.01.002

N/A

0DataRank · unranked

5 citations

Susan Y. Chon, Mario L. Marques‐Piubelli, Emily Y. Chu, Jonathan L. Curry